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Human mesenchymal stem cells promote CD34þhematopoietic stemcell proliferation 
with preserved red blood cell differentiation capacity 
ABSTRACT 
Studies showed that co-transplantation of mesenchymal stem cells (MSCs) and cord blood-
derived CD34
+
 hematopoietic stem cells (HSCs) offered greater therapeutic effects but little 
is known regarding the effects of human Wharton's jelly derived MSCs on HSC expansion 
and red blood cell (RBC) generation in vitro. This study aimed to investigate the effects of 
MSCs on HSC expansion and differentiation. HSCs were co-cultured with MSCs or with 
10% MSCs-derived conditioned medium, with HSCs cultured under standard medium served 
as a control. Cell expansion rates, number of mononuclear cell post-expansion and number of 
enucleated cells post-differentiation were evaluated. HSCs showed superior proliferation in 
the presence of MSC with mean expansion rate of 3.5 × 108  ± 1.8 × 107 after day 7 compared 
to the conditioned medium and the control group (8.9 × 107  ± 1.1 × 108 and 
7.0 × 107  ± 3.3 × 106 respectively, P < 0.001). Although no significant differences in RBC 
differentiation were observed between groups at passage IV, the number of enucleated cell 
was greater compared to earlier passages, indicating successful RBC differentiation. Cord 
blood-derived CD34
+
 HSCs can be greatly expanded by co-culturing with MSCs without 
affecting the RBC differentiation capability, suggesting the importance of direct MSC-HSCs 
contact in HSC expansion and RBC differentiation. 
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